cyclopentane has been researched along with Atherosclerotic Parkinsonism in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ajayi, AM; Alabi, AO; Bakre, AG; Ben-Azu, B; Umukoro, S | 1 |
| Danysz, W; Karcz-Kubicha, M; Lorenz, B | 1 |
| Hattori, F; Inoue, N; Matsui, A; Matsuo, H; Nasu, R; Ohtani, H; Sawada, Y; Takanaga, H | 1 |
3 other study(ies) available for cyclopentane and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Methyl jasmonate abrogates rotenone-induced parkinsonian-like symptoms through inhibition of oxidative stress, release of pro-inflammatory cytokines, and down-regulation of immnopositive cells of NF-κB and α-synuclein expressions in mice.
Topics: Acetates; alpha-Synuclein; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Behavior, Animal; Brain Chemistry; Cyclopentanes; Cytokines; Male; Mice; NF-kappa B; Oxidative Stress; Oxylipins; Parkinson Disease, Secondary; Psychomotor Performance; Rotenone; Uncoupling Agents | 2019 |
GlycineB antagonists and partial agonists in rodent models of Parkinson's disease--comparison with uncompetitive N-methyl-D-aspartate receptor antagonist.
Topics: Animals; Antiparkinson Agents; Binding, Competitive; Catalepsy; Cyclopentanes; Drug Evaluation, Preclinical; Drug Synergism; Excitatory Amino Acid Antagonists; Glycine Agents; Haloperidol; Hypnotics and Sedatives; Levodopa; Male; Neuroprotective Agents; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reserpine | 1999 |
Propiverine-induced Parkinsonism: a case report and a pharmacokinetic/pharmacodynamic study in mice.
Topics: Animals; Antitussive Agents; Benzilates; Catalepsy; Cholinergic Antagonists; Cyclopentanes; Male; Mandelic Acids; Mice; Neostriatum; Parkinson Disease, Secondary; Pharmaceutical Solutions; Propafenone; Receptors, Cholinergic; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2000 |